Climb Bio, Inc. Common Stock (NASDAQ: CLYM) last traded at $17.28, up 1.53% on the session. The quote above updates while this page is open; the figures below are drawn from Climb Bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
Climb Bio, Inc. Common Stock trades on NASDAQ under the ticker CLYM. Its market capitalisation is $992.50 million.
Valuation measures for Climb Bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $992.50M |
|---|---|
| Enterprise value | $955.14M |
| Price / book | 4.14 |
| Beta | 1.87 |
Trailing-twelve-month figures tagged in Climb Bio, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$57.62M |
|---|---|
| EPS (TTM) | -$0.820 |
| Return on equity | -24.06% |
| Cash | $44.11M |
Range and volume for CLYM over the past 52 weeks.
| 52-week high | $18.14 |
|---|---|
| 52-week low | $1.54 |
| Volume | 946.4K |
| Average volume | 1.32M |
| Previous close | $17.02 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.